Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from CLEO Diagnostics Ltd ( (AU:COV) ) is now available.
Cleo Diagnostics Ltd has requested a trading halt on its securities pending a significant announcement related to a material capital raise. This move is intended to help the company manage its continuous disclosure obligations and is expected to impact its market operations and stakeholder interests. The halt will remain until the announcement is made or normal trading resumes on 19 December 2025.
The most recent analyst rating on (AU:COV) stock is a Buy with a A$1.15 price target. To see the full list of analyst forecasts on CLEO Diagnostics Ltd stock, see the AU:COV Stock Forecast page.
More about CLEO Diagnostics Ltd
Cleo Diagnostics Ltd operates in the medical diagnostics industry, focusing on developing advanced diagnostic solutions. The company is listed on the Australian Securities Exchange under the ticker COV and is headquartered in Melbourne, Australia.
Average Trading Volume: 240,166
Technical Sentiment Signal: Buy
Current Market Cap: A$91.23M
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.